23andMe founder Anne Wojcicki will regain management of embattled DNA firm in any case

In a shock twist, 23andMe founder and former CEO Anne Wojcicki is about to regain management of the DNA firm’s belongings, according to a press release from 23andMe. In Might, an organization known as Regeneron bought 23andMe for $256 million in a chapter public sale, however Wojcicki’s nonprofit, TTAM Analysis Institute, was in a position to reopen bidding with an “unsolicited supply” of $305 million, The Wall Street Journal reports.

A chapter decide agreed to reopen bidding on 23andMe below the situation that Regeneron prime Wojcicki’s proposed value by at the very least $10 million, in accordance with WSJ. Regeneron declined, leaving 23andMe in TTAM’s management assuming the decide approves the deal. A listening to to contemplate the brand new deal is about for June 17, 2025.

Regeneron had beforehand deliberate to maintain on all the firm’s staff and proceed providing shopper DNA testing kits. In addition to answering clients’ questions on their ancestry, 23andMe’s genetic information is effective as a approach to establish potential well being dangers, and within the case of Regeneron, as a software for figuring out drug targets.

It isn’t fully clear what Wojcicki intends to do subsequent, however 23andMe’s announcement features a listing of buyer information and privateness protections TTAM Analysis Institute has agreed to, together with persevering with to permit clients to delete their information and opt-out of analysis, establishing a Shopper Privateness Advocacy Board and promising to “not promote or switch genetic information” within the occasion of one other chapter — except the customer agrees to the identical privateness protections.

Sustaining management of the corporate’s belongings has been Wojcicki’s plan since 23andMe declared bankruptcy in March 2025. She initially resigned as the corporate’s CEO to make a bid on the corporate.

“I’m thrilled that TTAM Analysis Institute will be capable to proceed the mission of 23andMe to assist folks entry, perceive and profit from the human genome,” Wojcicki says. “We imagine it’s vital that people are empowered to have selection and transparency with respect to their genetic information and have the chance to proceed to study their ancestry and well being dangers as they want.”

23andMe had a turbulent few years previous to declaring chapter, struggling an information breach in 2023 that impacted millions of customers and mass layoffs in 2024 that affected 40 percent of the corporate’s employees.

When you purchase one thing by way of a hyperlink on this article, we might earn fee.